Title: Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Journal: Journal of medicinal chemistry 20081113
886047-22-9 | LY2119620 | AA01DOXT | MFCD27996043
84082-34-8 | Vaccinium myrtillus,ext. | AA01DQ1O | MFCD00802960
1489399-71-4 | 2-(OXOLAN-3-YL)PROPANOIC ACID | AA01DQVW | MFCD21921772
1931965-01-3 | (S)-3-((TERT-BUTOXYCARBONYL)AMINO)HEXANOIC ACID | AA01DSRQ | MFCD06227925
1370256-43-1 | 4-(2,3-dimethylphenyl)piperidine hydrochloride | AA01DT8J | MFCD28109049
952195-21-0 | 3-(bromomethyl)-4-methyl-1,2-oxazole | AA01DTBG | MFCD30742131
1792190-69-2 | trans-tert-butyl (4aS,8aS)-2,3,4,4a,5,7,8,8a-octahydropyrido[4,3-b][1,4]oxazine-6-carboxylate | AA01DTJ0 | MFCD14581085
656257-49-7 | 1-Morpholino-2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)ethanone | AA01DTNM | MFCD18379051
2177259-22-0 | Tert-Butyl1,9-Diazaspiro[5.5]Undecane-9-Carboxylate Oxalate | AA01DTTD | MFCD28992048
2177258-16-9 | (S)-2-(3,4-Difluorophenyl)pyrrolidine hydrochloride | AA01DU4V | MFCD08751480